As filed with the Securities and Exchange Commission on July 21, 2023 |
Registration No. 333-254083 Registration No. 333-259210 Registration No. 333-265481 Registration No. 333-272679 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-254083
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-259210
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-265481
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-272679
UNDER
THE SECURITIES ACT OF 1933
IDEX Biometrics ASA
(Exact name of registrant as specified in its charter)
Kingdom of Norway |
Not applicable |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
|
|
Dronning Eufemias gate 16 Oslo, Norway |
NO-0191 |
(Address of Principal Executive Offices) |
(Zip code) |
IDEX Biometrics ASA 2020 Subscription Rights Incentive Plan
IDEX Biometrics ASA 2020 Employee Share Purchase Plan
IDEX Biometrics ASA 2021 Subscription Rights Incentive Plan
IDEX Biometrics ASA 2021 Employee Share Purchase Plan
IDEX Biometrics ASA 2022 Subscription Rights Incentive Plan
IDEX Biometrics ASA 2022 Employee Share Purchase Plan
IDEX Biometrics ASA 2023 Subscription Rights Incentive Plan
IDEX Biometrics ASA 2023 Employee Share Purchase Plan
(Full titles of the plans)
IDEX America Inc.
187 Ballardvale Street, Suite B211
Wilmington, Massachusetts 01887
(Name and address for agent for service)
+ 1 (339) 215-8020
(Telephone number, including area code, of agent for service)
Copies to:
Joshua A. Kaufman Marc A. Recht David C. Boles Cooley LLP 55 Hudson Yards New York, New York 10001 +1 212 479 6000 |
|
Carl Garmann Clausen Advokatfirmaet Ræder AS Postboks 2944 Solli NO-0230 Oslo Norway +47 23 27 27 00 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☒ |
|
|
|
|
|||
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|||
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
These Post-Effective Amendments relate to the following Registration Statements on Form S-8 (collectively, the “Registration Statements”), filed by IDEX Biometrics ASA (the “Registrant”) with the Securities and Exchange Commission (the “SEC”):
In accordance with undertakings made by the Registrant in each the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that were registered for issuance that remain unsold at the termination of the offering, the Registrant hereby removes from registration all of such securities of the Registrant registered but unsold under each of the Registration Statements. As a result of this deregistration, no securities remain registered for sale pursuant to the Registration Statements.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing of these amendments to Form S-8 and has duly caused these Registration Statement amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Wilmington, Commonwealth of Massachusetts, on July 21, 2023.
IDEX BIOMETRICS ASA |
||
|
|
|
By: |
|
/s/ Vincent Graziani |
|
|
Vincent Graziani |
|
|
Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
||
/s/ Vincent Graziani Vincent Graziani |
|
Chief Executive Officer (Principal Executive Officer) |
|
July 21, 2023 |
|
|
|
||
/s/ Eileen M. Wynne Eileen M. Wynne |
|
Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
|
July 21, 2023 |
|
|
|
||
/s/ Lawrence John Ciaccia Lawrence John Ciaccia |
|
Chair |
|
July 21, 2023 |
|
|
|
||
/s/ Deborah Lee Davis Deborah Lee Davis |
|
Deputy chair |
|
July 21, 2023 |
|
|
|
||
/s/ Annika Olsson Annika Olsson |
|
Director |
|
July 21, 2023 |
|
|
|
||
/s/ Morten Opstad |
|
Director |
|
July 21, 2023 |
Morten Opstad |
|
|
|
|
|
|
|
||
/s/ Adriana Saitta |
|
Director |
|
July 21, 2023 |
Adriana Saitta |
|
|
|
|
|
|
|
||
/s/ Stephen Andrew Skaggs Stephen Andrew Skaggs |
|
Director |
|
July 21, 2023 |
SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE OF THE REGISTRANT
Pursuant to the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of the registrant has signed this registration statement or amendment thereto on July 21, 2023.
IDEX AMERICA INC. |
||
|
|
|
By: |
|
/s/ Vincent Graziani |
Name: |
|
Vincent Graziani |
Title: |
|
Chief Executive Officer |
|
||
Authorized Representative in the United States |